Miranda Rexroat, PHARMD in Alexandria, IN - Pharmacist

Miranda Rexroat, PHARMD is a Pharmacist based in Alexandria, Indiana. Miranda Rexroat is licensed to practice in Indiana (license number 26022046A) and her current practice location is 105 N Park Ave, Alexandria, Indiana. She can be reached at her office (for appointments etc.) via phone at (765) 724-2210.

NPI number for Miranda Rexroat is 1235727967 and her current mailing address is 105 N Park Ave, Alexandria, Indiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1235727967.

Contact Information

	Miranda Rexroat, PHARMD
	105 N Park Ave, Alexandria, IN 46001-2055
	(765) 724-2210
	Not Available

Healthcare Provider's Profile

Full Name	Miranda Rexroat
Gender	Female
Speciality	Pharmacist
Location	105 N Park Ave, Alexandria, Indiana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1235727967
Provider Enumeration Date: 01/07/2021
Last Update Date: 01/07/2021

Medical Identifiers

Medical identifiers for Miranda Rexroat such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235727967	NPI	-	NPPES
00	Other		00

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	26022046A (Indiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Miranda Rexroat is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Miranda Rexroat, PHARMD 105 N Park Ave, Alexandria, IN 46001-2055 Ph: () -	Miranda Rexroat, PHARMD 105 N Park Ave, Alexandria, IN 46001-2055 Ph: (765) 724-2210

News Archive

Advances in thoracic surgery: an interview with Dan Wildman, VP Global Franchise Strategy & Innovation- Ethicon

Without a doubt, one of the most significant developments in thoracic surgery was the advent of video-assisted thoracoscopic surgery or VATS in the 1990s...

Research opens up possibility for new treatment approaches for motor neurone disease

New research from the University of Sheffield could offer solutions into slowing down the progression of motor neurone disease.

Kennedy death places leadership question mark on health care reform

NPR: "It was perhaps his biggest legislative disappointment that he hadn't managed to realize the goal of providing health insurance for every American. But along the way, he left a major mark on the nation's health care system" (Rovner, 8/26).

FDA: Randomized clinical trial necessary to better interpret Clolar's efficacy and safety in adult AML

Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.

Pharmacist in Alexandria, IN

Christopher Michael Day, PHARM.D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 105 N Park Ave, Alexandria, IN 46001
Phone: 765-724-2210

Miranda Rexroat, PHARMD - Pharmacist in Alexandria, IN